Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
20 May 2024
|
|
m 17:14 | Mantle cell lymphoma 3 changes history +757 [Jwarner (3×)] | |||
| m |
|
17:14 (cur | prev) +9 Jwarner talk contribs →Rituximab monotherapy {{#subobject:712b01|Regimen=1}} | |||
| m |
|
17:10 (cur | prev) +178 Jwarner talk contribs →Regimen variant #4, 18 doses {{#subobject:572f85|Variant=1}} | |||
| m |
|
17:08 (cur | prev) +570 Jwarner talk contribs →References | |||
19 May 2024
| m 00:38 | Mantle cell lymphoma diffhist +17 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} | ||||
16 May 2024
| m 00:00 | Mantle cell lymphoma diffhist -33 Jwarner talk contribs →First-line therapy, non-randomized or retrospective data | ||||
10 May 2024
| m 20:25 | Peripheral T-cell lymphoma diffhist +905 Jwarner talk contribs →CHOP {{#subobject:38ee4a|Regimen=1}} | ||||
9 May 2024
|
|
m 02:38 | Peripheral T-cell lymphoma 2 changes history +5 [Warner-admin (2×)] | |||
| m |
|
02:38 (cur | prev) -16 Warner-admin talk contribs Text replacement - "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1483" | |||
| m |
|
02:13 (cur | prev) +21 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf" to "https://www.nccn.org/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483" | |||
6 May 2024
| m 14:42 | Mantle cell lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" | ||||
25 April 2024
|
|
m 02:08 | Peripheral T-cell lymphoma 9 changes history +681 [Jwarner (9×)] | |||
| m |
|
02:08 (cur | prev) +65 Jwarner talk contribs | |||
| m |
|
02:05 (cur | prev) +50 Jwarner talk contribs →Mogamulizumab monotherapy {{#subobject:8d8ae3|Regimen=1}} | |||
| m |
|
02:04 (cur | prev) +182 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:372121|Regimen=1}} | |||
| m |
|
02:00 (cur | prev) +63 Jwarner talk contribs →Forodesine monotherapy {{#subobject:2310b4|Regimen=1}} | |||
| m |
|
01:58 (cur | prev) +84 Jwarner talk contribs →Chidamide monotherapy {{#subobject:5a869f|Regimen=1}} | |||
| m |
|
01:56 (cur | prev) +65 Jwarner talk contribs | |||
| m |
|
01:55 (cur | prev) +63 Jwarner talk contribs →DA-EPOCH {{#subobject:9b4e41|Regimen=1}} | |||
| m |
|
01:53 (cur | prev) +66 Jwarner talk contribs →CHOEP-14 {{#subobject:e84b92|Regimen=1}} | |||
| m |
|
01:53 (cur | prev) +43 Jwarner talk contribs →A-CHOP {{#subobject:75a3d2|Regimen=1}} | |||